Phototherapeutic Keratectomy



Phototherapeutic Keratectomy


Lee A. Snyder

Aaleya F. Koreishi

Christopher Starr

Walter J. Stark



The advent of the 193-nm argon-fluoride (ArF) excimer laser has provided corneal surgeons with a major therapeutic tool in the management of anterior corneal disease. Its potential for precise corneal ablations was demonstrated by Trockel and coworkers, who performed an ablation of a bovine cornea in 1983 (1). Seiler et al., in 1985, performed the first human excimer laser phototherapeutic keratectomy (PTK) in a sighted eye (2). The ability to ablate tissue with submicron accuracy, without damage to surrounding tissue, lends the excimer laser well to the removal of diseased layers of the anterior cornea and to the smoothing of its surface (1,3). In addition, the management of certain corneal diseases with PTK may delay or obviate the need for penetrating or lamellar keratoplasty and its associated risk and expense. The mechanism of action involves the use of high-energy ultraviolet radiation with a wavelength of 193 nm to break molecular bonds of proteins in the cornea. Tissue fragments are ejected at a high speed, minimizing transfer of energy to adjacent corneal structures (4,5).


CORNEAL WOUND HEALING

As the excimer laser is incorporated into the armamentarium of therapies used to treat corneal disease, its effect on corneal wound healing must be understood, for the complex manner in which the cornea heals plays a significant role in the final visual outcome of the procedure (6). The cornea is an intricate tissue that serves both to add structural support to the globe and to transmit and reflect light. The goals of laser therapy should include preservation of both its integrity and transparency.

After removal of the epithelium, reepithelialization typically occurs within 1 week, although reestablishment of the desmosomes and hemidesmosomes to the underlying stroma occurs 1 to 3 months later (1,7, 8, 9, 10, 11, 12, 13). There is some evidence for the formation of a pseudomembrane that covers the exposed ablated surface almost immediately after the procedure and may aid in reepithelialization (9,14,15). Stromal deposition occurs after epithelial regrowth, and may depend on the epithelium for the initiation of connective tissue synthesis (10).

Laser-induced scarring may be related to depth of ablation. Goodman et al. showed that ablations of less than 50 μm on rabbit corneas did not induce scarring, epithelial hyperplasia, or new collagen deposition (15). Wu et al., however, reported anterior stromal scarring with ablation depths of 50 to 113 μm on four eyes that underwent PTK followed by penetrating keratoplasty (PK) (3). Loss of endothelial cells has not been demonstrated in ablations that are within 40 μm of Descemet’s membrane (11,16, 17, 18).

PTK has also been shown to improve the health of the ocular surface. Dogru et al. recently reported that variables such as corneal sensitivity, tear function, and impression cytology parameters improve after PTK for granular/Avellino dystrophy and corneal scars (19,20). These improvements are maintained until the primary corneal dystrophy recurs (21).


PREOPERATIVE ASSESSMENT

Careful patient selection and surgical planning are crucial to successful outcomes in PTK. A thorough preoperative evaluation (Table 65-1) consists of a comprehensive review of the patient’s ocular and systemic history. Specific attention should be given to aspects of the history, including collagen vascular disorders, uncontrolled diabetes, or active inflammation, because they may adversely affect wound healing and represent contraindications to PTK (6). PTK should be avoided in eyes with severe keratoconjunctivitis sicca and stem cell deficiencies because they are prone to persistent epithelial defects that can, in turn, stimulate more scarring. Herpes simplex virus may be reactivated in the setting of PTK, and it is recommended that eyes with prior herpes infection be disease free for at least 1 year before PTK is attempted. In addition, prophylactic acyclovir or valacyclovir and topical trifluridine should be added to the PTK regimen (22, 23, 24).









TABLE 65-1. RECOMMENDED PREOPERATIVE EVALUATION OF PATIENTS UNDERGOING PHOTOTHERAPEUTIC KERATECTOMY



































History (ocular and systemic)


Visual acuity (uncorrected and best corrected)


Manifest refraction


Hard contact lens overrefraction (if necessary)


Pupillary examination


Extraocular motions


Confrontation visual fields


Intraocular pressure


Slit-lamp examination (corneal lesion size, depth, location)


Corneal sensation


Schirmer’s test (if necessary)


Keratometry


Topography


Pachymetry (ultrasonographic or optical)


Dilated funduscopic examination


Ultrasonography (if necessary)


A detailed ophthalmic examination, including uncorrected and best corrected visual acuity, manifest refraction with hard contact lenses if indicated, pupillary examination, tonometry, slit-lamp examination, keratometry and topography, as well as a dilated fundus examination, is an important part of preoperative planning. All layers of the cornea should be evaluated. PTK should be avoided in eyes with irregularities resulting from endothelial decompensation (6). Blepharitis should be treated before PTK is performed. If dry eye is suspected, Schirmer’s test should be performed. Patients should be informed that they may need to wear rigid gas-permeable (RGP) lenses after surgery to achieve their best corrected acuity, and therefore a trial of RGP contact lenses is recommended before embarking on PTK. If poor preoperative visual acuity is due to irregular astigmatism, RGP lenses may neutralize these corneal aberrations and obviate the need for PTK. Potential acuity can be assessed with hard contact lens overrefraction, pinhole acuity, or the Guyton-Minkowski potential acuity meter. Corneal topography is a helpful tool in planning surgical technique and in comparing preoperative with postoperative data. Finally, although altering refractive error is not the primary goal of PTK, the ablation can have significant effects on refractive error, and this should be kept in mind as the procedure is planned (25).

To qualify for PTK, the patient’s symptoms should be explained by the observable corneal pathologic process (Table 65-2). Furthermore, the lesion amenable to PTK should be located within the anterior 5% to 20% of the cornea. Depth can be estimated at the slit lamp with additional information obtained by optical pachymetry or ultrasonic biomicroscopy, both of which can be useful in planning for PTK (26, 27, 28, 29, 30). Pathologic processes limited to Bowman’s layer may be more amenable to mechanical epithelial debridement before attempted PTK. Treatment should be limited to areas of disease that are visually significant. It may not be necessary to remove all clinically observable opacities to achieve acceptable visual rehabilitation. As with other excimer laser procedures, the remaining stromal bed should be at least 250 μm thick to avoid the development of postoperative ectasia (6). Informed consent can be tailored to the specific PTK technique used based on the preoperative indications.








TABLE 65-2. CORNEAL PATHOLOGIC PROCESSES TREATABLE WITH PHOTOTHERAPEUTIC KERATECTOMY






































































Anterior corneal dystrophies



Map-dot-fingerprint



Reis-Buckler



Meesman’s



Lattice



Granular



Avellino



Fuchs’ endothelial



Salzmann’s nodular



Schnyder’s


Recurrent epithelial erosions


Corneal scars



Infectious



Herpetic



Trachomatous



Traumatic



Pterygium



Stevens-Johnson syndrome



Contact lens related


Other irregularities



Band keratopathy



Apical scars in keratoconus



Shield ulcers


Corneal intraepithelial dysplasia


The protocol for PTK should include laser calibration before use of the excimer laser. An adequate supply of gases needed for surgery, as well as calibration of laser fluence, must be ensured. This is usually accomplished by ablating a standardized material such as polymethylmethacrylate to ensure a flawless and homogeneous ablation (6). Proper centration of the beam and reticle alignment should be checked before each procedure. Pulse rate and spot size are chosen by the surgeon according to type of correction desired. Although these tasks may be delegated to a technician, the surgeon must verify results of the laser calibration.

Immediately before the procedure, the patient should be reexamined at the slit lamp to finalize the ablation strategy. Techniques vary depending on the location, diffuseness, and elevation of the underlying lesion. A topical anesthetic is applied to both eyes and the patient is positioned on the chair and centered under the operating microscope. A speculum is placed into the operative eye and focus is achieved under high magnification. The patient is then asked to stare at the red blinking light during the ablation.



SURGICAL TECHNIQUES

Because of the wide variety of pathologic processes amenable to phototherapeutic ablation, the surgeon must individualize the approach for each patient. Techniques of epithelial removal and patterns of stromal ablation vary depending on characteristics of the corneal lesion and treatment goals, but certain guidelines can be taken into account (Table 65-3).


Smooth Corneal Opacities

PTK can be a highly effective therapy for a central corneal pathologic process arising beneath a relatively smooth epithelial surface, as in many anterior stromal dystrophies (31). When the anterior corneal surface is smooth, or the lesion in Bowman’s membrane or anterior stroma is not causing significant surface irregularity, the goal of PTK is twofold. The first aim is to translate this smooth surface to a level deeper than the corneal lesion, and the second is to minimize the induced refractive error (6). In these cases, epithelial removal is best accomplished by the laser rather than by mechanical debridement. The epithelium itself acts as a masking agent to allow irregularities in Bowman’s layer and the superficial stroma to be differentially ablated. Some surgeons prefer to use a masking fluid on intact epithelium, ablating until the blue fluorescence disappears, signifying the point at which all epithelium has been ablated and stromal ablation begins (32,33). Manual epithelial debridement has been shown to be problematic for corneal dystrophies such as Reis-Buckler. Lawless et al. noted that manual epithelial removal in an eye with Reis-Buckler dystrophy was often patchy and the end point for complete removal difficult to assess (34, 35, 36).








TABLE 65-3. SUGGESTED SURGICAL TECHNIQUES FOR PHOTOTHERAPEUTIC KERATECTOMY OF SINGLE OR MULTIPLE LESIONS




























































Single Lesion


Multiple Lesions


IF elevated/calcific/fibrous:


IF sparse:



Initial mechanical debridement



Treat per single lesion protocol


THEN


IF dense lesions




AND




IF elevated/calcific/fibrous:





Initial mechanical debridement


IF peripheral:


THEN



Focal ablation to level of surrounding tissue with aggressive masking agent (moderate viscosity)


IF central:



Initial ablation with high-viscosity masking agent, large spot size, low pulse rate



Focal ablation just short of level of surrounding tissue with aggressive masking agent (moderate viscosity)



THEN


THEN



Complete ablation with moderate-viscosity masking agent



Complete ablation with large spot size and masking agent (moderate viscosity)


THEN




Taper ablation at border using 2-mm spot size to 20 μm depth


Modified from Azar DT, Steinert RF, Stark WJ, eds. Excimer laser phototherapeutic keratectomy: management of scars, dystrophies and PRK complications. Baltimore: Williams & Wilkins, 1997.


Because corneal dystrophies usually manifest as a diffuse pathologic area, a large spot size, measuring 6 to 7 mm, centered on the entrance pupil, can be used to ablate both epithelium and underlying anterior stroma. Initial depth of ablation should be 75% of the estimated depth of the corneal lesion. After the initial ablation, the surgeon examines the patient at the slit lamp to evaluate the effect, and to assess if further ablation should be done. The “ablate and check” method is performed until the desired bulk of diseased cornea is removed (31). The depth of the opacity can be difficult to assess with this technique, and care should be taken not to exceed the planned preoperative depth of ablation as determined by careful slit-lamp examination and optical pachymetry.

The surgeon must remember that as ablation depth increases, the change in refractive error also increases, and care should be taken to ablate the minimal amount of lesion needed to alleviate patient symptoms (6,37). Undertreatment is preferable to overtreatment because the procedure can be repeated.

Mechanical debridement is the preferred method for epithelial removal when treating recurrent epithelial erosions or any disorder in which the epithelium is deemed irregular compared with the underlying Bowman’s membrane. This can be accomplished manually with a Bard-Parker blade (38). The epithelium is removed over the area of erosion. If the visual axis is involved, it may be wise to include this area so as not to induce irregularities into the ablation profile. Masking fluid, such as 1% hydroxymethylcellulose, 0.5% tetracaine, or Tears Naturale, may be applied after manual debridement to smooth the surface before ablation (6). The ablation zone is chosen to encompass the area of debrided epithelium. A depth of 3 to 10 μm is usually sufficient to remove a portion of Bowman’s layer (6,31,37).


To smooth the resultant stromal bed for epithelialization and to reduce the magnitude of induced hyperopia after performing a large central ablation, a transition zone can be created. Approximately 1 D of hyperopic shift is induced for every 20 μm of stromal ablation (6). Sher et al. used a circular motion of the eye to perform a “smoothing technique” (34). The Summit excimer laser trials used a related “polish technique” whereby the patient’s head was moved in a brisk circular manner under the laser (39,40). Subsequently, Stark et al. described a “modified taper technique” whereby the surgeon moves the eye in a circular fashion under the laser, treating the periphery of the ablation zone with a 20-μm deep, 2-mm diameter spot size. The additional peripheral ablation limits induced hyperopia by approximately 2 to 4 D (7,40). Alternatively, a hyperopic photorefractive keratectomy (PRK) ablation may be used after PTK to minimize induced hyperopia. In this circumstance, epithelial ablation should be carried out to 8 mm. Combining PTK with PRK is technically easier and potentially more precise than the polish techniques; however, it requires additional costs for the hyperopic card and removes additional central as well as peripheral tissue. From previous studies, it is known that approximately 1 D of hyperopic shift is induced for every 20 μm of stromal ablation (6), and the depth of both the PTK and PRK ablations should be considered in the total tissue removed. Care should be taken to avoid too much thinning of the peripheral cornea because a corneal transplantation may be considered at a later time. PTK combined with PRK can also be considered for PTK candidates who have concurrent myopia.


Scars and Nodules

Allowing the precise removal of a predefined amount of corneal tissue, PTK is well suited for ablation of elevated scars and nodules. Such lesions can be seen in keratoconus, Salzmann’s degeneration, and posttraumatic or infectious scars. Decreased vision may be secondary to opacification, surface irregularities, or associated refractive errors (6). Again, disease limited to the anterior stroma is most amenable to PTK. Unlike ablation of smooth corneal lesions, with the treatment of elevated nodules or scars, the goal is to smooth the lesion selectively, while simultaneously limiting refractive change. It is best to measure the densest portion of the scar in the optical zone using the optical pachymeter, and to limit ablation to the depth determined before surgery. Because the excimer laser removes surface tissue and does not automatically smooth contour irregularities, any preexisting irregularities will be duplicated at a deeper level if ablation rate and spot size stay constant (41). In addition, scars or calcific lesions may ablate more slowly than normal corneal tissue, and the excimer laser can induce respective peaks and valleys in the contour that were not present before treatment (42, 43, 44). Finally, selective ablation of central lesions can lead to large hyperopic shifts, whereas ablation of peripheral lesions can induce myopia (6).

The importance of surface modulators in these circumstances to aid in smoothing the contour of the areas to be treated cannot be overestimated. The smooth contour created by these modulators can be translated to the new postablation surface (6). Fluid masking agents, which fill valleys in the corneal surface, are probably the most commonly used type of surface modulator. These fluids include 0.9% saline (Unisol), 1% carboxymethylcellulose sodium (Celluvisc), and 0.3% hydroxypropylmethylcellulose 2910 with 0.01% dextran 70 (Tears Naturale II). These solutions all exhibit sufficient absorbance by the 193-nm ArF laser, although 0.3% hydroxypropylmethylcellulose 2910 and a 0.1% dextran 70 solution showed greater absorbance than 0.9% saline (41). The viscosity of a masking fluid should be high enough to remain in surface depressions without run-off and low enough to coat the surface uniformly. A thin layer of fluid should be applied with a damp cellulose sponge. A “sight and sound” method can be used to assess the adequacy of the application. Because the excimer laser turns many masking fluids white, a white area overlying a peak indicates that too thick a layer of fluid has been applied. Because ablation of the fluid emits a soft “click” versus the loud “snap” of naked cornea, a louder treatment than predicted signifies deficient coverage of fluid on the cornea (39). The fluid may need to be reapplied several times to attain the desired layering throughout the procedure.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Sep 18, 2016 | Posted by in OPHTHALMOLOGY | Comments Off on Phototherapeutic Keratectomy

Full access? Get Clinical Tree

Get Clinical Tree app for offline access